e-learning
resources
Munich 2006
Sunday 03.09.2006
Landmark developments in lung function testing: 2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IsovolumeFEF
25-75%
6 and FEV
1
for identifying bronchodilator response
M. P. Swanney, L. E. Beckert, C. M. Frampton, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America)
Source:
Annual Congress 2006 - Landmark developments in lung function testing: 2006
Session:
Landmark developments in lung function testing: 2006
Session type:
Oral Presentation
Number:
977
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, C. M. Frampton, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). IsovolumeFEF
25-75%
6 and FEV
1
for identifying bronchodilator response. Eur Respir J 2006; 28: Suppl. 50, 977
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Verification of flow rate stability in high-flow nasal cannula devices
DLCO biological controls in clinical practice.
Related content which might interest you:
How often FEV
1
underestimates bronchodilator response?
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003
Comparison of bronchodilatator response of FEV
1
and airway resistance
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003
FEF
25-75%
should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005
Immediate bronchodilator response in FEV
1
as a diagnostic criterion for adult asthma
Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018
Year: 2019
Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
Influence of basal FEV
1
on the response to bronchodilator agents in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio
Source: Eur Respir J 2007; 30: Suppl. 51, 744s
Year: 2007
Maximally attained level of FEV
1
and FEV
1
decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV
1
and FEV
1
in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005
Differentiation of bronchodilator effects of indacaterol and formoterol by FEV
1
and inspiratory capacity (IC) in patients with COPD
Source: Annual Congress 2007 - New drugs for COPD
Year: 2007
The role of forced partial expiratory flows to test the bronchodilator response in COPD
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012
A comparison of the response to inhaled histamine measured with FEV
1
and sGaw in healthy subjects
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010
The influence of FVC manoeuvres on consecutive FEV
1
values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept